Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-09-2022 | Lymphoma | Case report

Ribavirin/sofosbuvir

Hepatic large B-cell lymphoma: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Zaimi Y, et al. Primary hepatic large B-cell lymphoma following direct-Acting antiviral treatment for hepatitis C. BMJ Open Gastroenterology 8: No. 1, 16 Aug 2021. Available from: URL: http://bmjopengastro.bmj.com/ Zaimi Y, et al. Primary hepatic large B-cell lymphoma following direct-Acting antiviral treatment for hepatitis C. BMJ Open Gastroenterology 8: No. 1, 16 Aug 2021. Available from: URL: http://​bmjopengastro.​bmj.​com/​
Metadata
Title
Ribavirin/sofosbuvir
Hepatic large B-cell lymphoma: case report
Publication date
01-09-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-24218-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Oxycodone